|Legal Status||To be confirmed|
A 2-chloro derivative of diazepam which is not licensed for medicinal use.
There is a lack of published scientific evidence for this substance and no cases of poisoning have been documented in the literature (Toxbase 28/08/14).
|Short Term Effects||
Benzodiazepines commonly cause drowsiness, ataxia, dysarthria and nystagmus. Coma, hypotension, bradycardia and respiratory depression occasionally occur but are seldom serious if these drugs are taken alone. Coma usually lasts only a few hours but may be prolonged in elderly patients. Benzodiazepine respiratory depressant effects are more serious in patients with severe chronic obstructive airways disease. Severe effects in overdose also include rhabdomyolysis and hypothermia. Co-ingestion of alcohol and other central nervous system depressants potentiates the effects of benzodiazepines and can increase toxicity.
Identified in Poland: • N-(2-(dimethylamino)cyclohexyl)-N-methylbenzo[d][1,3]dioxole-5-carboxamide (3,4-methylenedioxy-U-47700)a NPS Opioid
There have been recent deaths and hospitalisations relating to substance use at festivals.: Be aware that over the past few years there has been an increase in the dosage and purity of substances available, in particular MDMA ‘Ecstasy’ pills. Increased purity and dosage means an increase in potential for adverse effects. Pills and powders etc.. may not contain what is intended, different substances have different doses,effects, time of onset and duration. Where WEDINOS have tested pressed pills; the result relates only to the samples analysed and cannot be used to indicate the contents, profile or quality of a wider batch of the substance. This is always the case despite pills having the same logo, shape size and colour.